跳至主要内容
临床试验/jRCT1070230032
jRCT1070230032进行中(未招募)不适用

A Radiogenomics biomarker for predicting mutation sutatus and gene expresioon in hepatocellular carcinoma

Kurume University School of Medicine0 个研究点目标入组 200 人开始时间: 2023年5月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
No limit 至 No limit(—)
性别
All

入选标准

  • Diagnosed as HCC, and undergone surgery without any systemic therapy from April 2019 to April 2023 in Kurume univesity
  • Availabirity of contrast-enhanced CT images within 12 weeks before surgery and tumor tissue storage in Kurume university
  • 3.Acquired informed consent form about use of tumor tissue before surgery in Kurume university

排除标准

  • Not applicable participants determined by an investigator

结局指标

主要结局

-

Evaluation of machine learning model for predicting B-catenin mutation from image features

次要结局

未报告次要终点

研究者

发起方
Kurume University School of Medicine

相似试验